We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Lung Ultrasound Could Predict Worsening in COVID-19 Patients

By HospiMedica International staff writers
Posted on 15 Dec 2020
A new method using ultrasound imaging could serve as a diagnostic tool to help physicians predict if a patient with COVID-19 will worsen.

For some, COVID-19 can result in severe pneumonia or even death, while others remain purely asymptomatic. More...
Researchers at the Policlinico San Matteo (Pavia, Italy) have developed a method using ultrasound imaging to score a patient's lung health, which is indicative of their outcome. The ability to predict when a patient might worsen can help physicians be better prepared for caring for patients.

The researchers tested the tool on 52 patients who had been admitted to San Matteo Hospital between March 15 and April 29. They administered lung ultrasounds to the patients on arrival and before discharge to get a peek into the state of their lungs. Using 14 points in the lungs, the researchers looked for abnormalities, such as pleural irregularities, and assigned each spot a score out of 3 based on its severity.

Adding up all the points, the researchers found the total lung ultrasound score was higher for those who had a worsening outcome of COVID-19, such as needing supplementary oxygen, admission to intensive care, or death. Patients with at least three spots scoring 3 or with high overall scores were more than six times more likely to have a worsening outcome than other patients.

From their results, the researchers proposed a graph called a nomogram that can help physicians compute the probability a patient will worsen based on their lung ultrasound score. The diagnostic will help physicians rapidly evaluate and predict how a patient will worsen due to COVID-19. The test is also quick to perform. A scan of each spot takes 10 seconds, making the whole exam last only 15 to 20 minutes.

Related Links:
Policlinico San Matteo


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Pediatric Mask
Respire SOFT
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Coredio’s CPSE is a a software-as-a-medical-device platform designed for use with consumer smartwatches and standard blood pressure cuffs in clinical and home settings under physician supervision (Photo courtesy of Coredio)

AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure

Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.